Company Overview and News
A gas pipeline operated by Enbridge exploded, sending flames shooting towards the sky on Tuesday evening in the community of Shelley, northeast of Prince George, B.C.
As if stuck on repeat, oil and natural gas were up, midstream was down this week. The S&P 500 paused its upward trajectory, and utilities were negative for a second straight week. Income securities had a rough month generally, and it feels like midstream is being painted with the "income stock" brush rather than the "energy stock" brush.
BKEP TGE AMID PAGP WGP SEP ANDX AM EQM NBLX EQGP OKE EEP FGP MPLX TLP ENLK GLNG SE ETP TCP GMLP DM WES SEMG
When I first started building my business more than twenty years ago I realized that I was taking a path less traveled. As a business owner I would be forging my own way, making my own decisions and getting paid based on my own abilities. My good fortune was achieved because of the relationships I created with my customers and my ability to identify new trends and meet their ever changing needs. But while I was building that business I was also building another in the background.
ENB ENB SE
2018-09-10 seekingalpha - 1
Welcome to a new format where I present international dividend stocks with high dividend increases in the last month. Growing dividends is what many long-term investors are looking for. And they are right, because an income made of dividends based on high quality stocks is much safer than any single job in the world. Even better, dividend growth mostly exceeds salary increases by far.
ENB CNUTF ENB CDUAF SE CU
2018-09-04 seekingalpha - 2
Stephen Mandel’s 13F portfolio value decreased ~4% from $19.74B to $18.91B. The number of positions decreased from 30 to 28.
STZ.B FB CP SQNXF NOW PYPL GOOG NVDA ADBE ATVI DLTR CP AMZN AVGO CSX MELI TSM IQV EA SQ WYNN TDG TRU TMUSP TMUS STZ EXAS SE BABA BLK BKNG GOOGL MSFT BRCM MHK UNH SBAC
Enbridge Inc. is sweetening its offer to buy all the units in Spectra Energy Partners LP it doesn't already own, raising its proposed share exchange ratio by almost 10 per cent in the all-shares transaction valued at $4.3 billion.
ENB ENBBF CQP EBGUF LNG DTK EBBNF ENB EEP SEP SE
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
ENBBF ENB ETP EBBNF ENB SEP SE
Over the last couple of years, the North American pipeline industry has seen a high amount of mergers and acquisitions. One of the companies that made a major play was Enbridge (ENB), which acquired Spectra Energy for $28 billion.
ENB EBGUF ENB EEP SEP SE
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to SE / Spectra Energy Corp. on message board site Silicon Investor.
as of ET